{"id":199997,"name":"OREXO US, INC.","slug":"orexo-us-inc","state":"NJ","country":"United States of America","description":"Pharmaceutical Company","totalSpending":910000,"filings":32,"yearlySpending":[{"year":2018,"income":90000},{"year":2019,"income":100000},{"year":2020,"income":240000},{"year":2021,"income":180000},{"year":2022,"income":180000},{"year":2023,"income":120000},{"year":2024,"income":0},{"year":2025,"income":0}],"issues":["PHA"],"firms":["CONNECT 4 STRATEGIES, LLC"],"lobbyists":["SAIRA CHIRICO"],"govEntities":["Centers For Medicare and Medicaid Services (CMS)","HOUSE OF REPRESENTATIVES","SENATE","Food & Drug Administration (FDA)"],"sampleDescriptions":["s916 Access to Emergency Medications Act","s916 Access to Emergency Medications Act\nMedication assisted therapy - opioids","s2680 / HR 6 Opiod Crisis Response Act 2018\nMedication assisted therapy - opioids","Medicare and Medicaid access","Medicare and Medicaid access"],"years":[2018,2019,2020,2021,2022,2023,2024,2025]}